– Company creating de novo designed macrocycleswith enhanced efficacythat precisely target disease biology– Vilya’s privileged macrocycles have the potential to be applied across broad therapeutic areas, addressing large unmet medical needsSEATTLE, April 25, 2024 (GLOBE NEWSWIRE) — VILYA, Inc. (Vilya), a biotechnology company creating a…

Finance

Latest News

View More
© 2024 The Business Times. All Rights Reserved.